Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma

Doxorubicin (Dox) is one of the most important first-line drugs used in osteosarcoma therapy. Multiple and not fully clarified mechanisms, however, determine resistance to Dox. With the aim of identifying new markers associated with Dox-resistance, we found a global up-regulation of small nucleolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Godel, Martina, Morena, Deborah, Ananthanarayanan, Preeta, Buondonno, Ilaria, Ferrero, Giulio, Hattinger, Claudia M., Di Nicolantonio, Federica, Serra, Massimo, Taulli, Riccardo, Cordero, Francesca, Riganti, Chiara, Kopecka, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349977/
https://www.ncbi.nlm.nih.gov/pubmed/32599901
http://dx.doi.org/10.3390/ijms21124500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349977/
https://www.ncbi.nlm.nih.gov/pubmed/32599901
http://dx.doi.org/10.3390/ijms21124500

Ejemplares similares